We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SKBN:TASEShikun & Binui Ltd. Analysis

Data as of 2026-06-13 - not real-time

ILA 2,149.00

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Shikun & Binui (SKBN) is trading at 2,149 ILA, just above its 20‑day SMA of 2,138 and comfortably over the 50‑day SMA of 2,036, indicating a short‑term price momentum that aligns with a bullish trend direction. However, the MACD histogram is deep in negative territory (‑17.39) and the MACD signal line flags a bearish crossover, while volume is on a decreasing trend, suggesting weakening buying pressure. The RSI sits at a neutral 53.6, offering no clear overbought or oversold signal, and the stock sits midway between its support at 1,968 and resistance at 2,284, leaving limited upside cushion. On the fundamentals side, the company posts a negative profit margin (‑4.2%), a ROE of ‑9.5%, and a staggering debt‑to‑equity ratio of 188.8, with total debt (~14 B ILA) far exceeding cash reserves (~2.8 B ILA). Forward earnings expectations imply a PE of 37.7, well above the industry average of 30.6, while the high 30‑day volatility of 46% and beta around 0.85 underscore elevated market risk.
Given the disconnect between the technical bullish bias and the deteriorating financial health, the stock appears overvalued and carries significant downside risk if earnings do not improve. The absence of any dividend further diminishes its appeal for income‑focused investors. Investors should weigh the short‑term price resilience against the long‑term leverage and cash‑flow challenges before deciding on exposure.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish MACD crossover
  • Decreasing volume trend
  • Proximity to resistance at 2,284

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • High leverage and negative cash flow
  • Neutral RSI and mixed technical signals
  • Potential for operational turnaround in infrastructure projects

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • Unsustainable debt‑to‑equity ratio
  • Negative profitability and ROE
  • Overvaluation relative to earnings outlook

Key Metrics & Analysis

Financial Health

Revenue Growth-6.50%
Profit Margin-4.21%
P/E Ratio37.7
ROE-9.47%
ROA-0.32%
Debt/Equity188.78
P/B Ratio2.9
Op. Cash FlowILA-340000000
Free Cash FlowILA-1682375040
Industry P/E30.6

Technical Analysis

TrendBullish
RSI53.6
SupportILA 1,968.00
ResistanceILA 2,284.00
MA 20ILA 2,138.10
MA 50ILA 2,035.84
MA 200ILA 1,825.66
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

GradeOvervalued
TypeValue

Risk Assessment

Beta0.85
Volatility46.38%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.